Ryman Healthcare Limited

Ryman Healthcare Limited

RYM.NZ
Ryman Healthcare LimitedNZ flagNew Zealand Exchange
2.29
NZD
+0.03
- -
2.33BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
0.32
0.36
0.4
0.46
0.51
0.6
0.68
0.75
0.8
0.89
1.02
0.89
1.01
Basic EPS, GAAP
0.24
0.35
0.43
0.54
0.63
0.69
0.58
0.47
0.75
1.23
0.47
0.01
-0.62
Free Cash Flow per Basic Share
0.29
0.27
0.2
0.32
0.23
-0.33
-0.28
-0.49
-0.41
-0.53
-0.59
-0.24
-0.15
Dividend per Share
0.08
0.1
0.11
0.13
0.15
0.17
0.19
0.21
0.19
0.2
0.12
- -
- -
Book Value per Share
1.09
1.33
1.65
2.05
2.53
3.04
3.42
3.67
4.29
5.32
7.41
5.57
5.85
Tangible Book Value per Share
1.3
1.64
1.95
2.36
2.92
3.41
3.8
4.02
4.95
6
8.35
5.93
5.98
Basic Weighted Avg Shares
563
563
563
563
563
563
563
563
563
563
548
730
710
Sales/Revenue/Turnover
180
202
226
260
288
341
381
422
452
504
560
651
714
Operating Margin (%)
22.26
18.65
14.46
16.62
16.65
15.25
14.2
10.48
5.47
0.36
-3.53
-10.7
-16.57
Depreciation Expense
8
9
11
13
15
21
23
29
32
36
47
44
48
Net Income, GAAP
137
195
242
305
357
388
326
265
423
693
258
5
-437
Effective Tax Rate (%)
9.02
4.17
0.05
1.26
1.73
0.16
1.04
- -
- -
4.05
- -
- -
- -
Profit Margin (%)
75.8
96.49
107.15
117.44
123.69
113.99
85.57
62.71
93.51
137.54
46.03
0.73
-61.2
Working Capital
-3
-153
-14
14
-56
143
144
84
373
160
329
441
-674
LT Debt
226
277
1,987
2,399
2,975
1,060
1,324
1,757
2,834
3,386
2,227
2,569
1,695
Total Equity
734
927
1,101
1,328
1,652
1,941
2,170
2,301
2,829
3,435
4,664
4,418
4,261
Return on Invested Capital (%)
3.9
3.27
1.51
1.25
1.13
1.36
1.65
- -
- -
0.03
- -
- -
- -
Return on Capital (%)
17.86
21.35
12.69
9.72
9.22
11.28
11.44
- -
- -
12.41
- -
- -
- -
Return on Common Equity (%)
24.04
28.55
28.81
29.31
27.66
24.74
17.9
13.24
18.85
25.58
7.3
0.12
-10.63

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.16%
14.26%
-3.54%
Free Cash Flow
-20.99%
-12.48%
-37.81%
Net Income, GAAP
-926.86%
-1,857.13%
-9,248.29%
Sales/Revenue/Turnover
12.24%
11.12%
9.72%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
560
2024
- -
- -
- -
- -
651
2025
- -
- -
- -
- -
714

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.47
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
-0.62

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.12
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Naomi James
Full Time Employees
7,700
Sector
Healthcare
Industry
Medical - Care Facilities
Address
Airport Business Park Christchurch New Zealand 8042
IPO Date
Jan 4, 2000
Business
Ryman Healthcare Limited develops, constructs, owns and operates retirement villages, rest homes and aged care facilities in New Zealand and Australia. The company offers independent living apartments and townhouses; serviced apartments with housekeeping and daily meals; rest home care; hospital-level care; specialist dementia care; and respite care services through an integrated continuum of care model across its villages, which include resort-style amenities such as indoor pools, gyms, libraries and movie theatres. Ryman Healthcare serves over 15,000 residents in 49 operational villages, with 48 in New Zealand and eight in the Melbourne area of Australia, targeting seniors seeking retirement living and aged care; it employs approximately 7,700 staff. Founded in 1984 by John Ryder and Kevin Hickman and headquartered at 92D Russley Road, Christchurch, New Zealand, the company lists on the NZX under ticker RYM and the ASX. In February 2025, Ryman Healthcare completes a NZ$1 billion equity raise comprising a NZ$313 million institutional placement and a NZ$688 million pro-rata entitlement offer to reset its balance sheet and reduce gearing; in November 2025, it refinances NZ$2 billion syndicated loan facilities with a five-year average tenor and lists on the ASX on 1 October 2025 to broaden investor access; during 1H26 ending September 2025, it achieves first positive free cash flow of NZ$56.2 million, lifts annualised cost savings target to NZ$50-60 million, raises occupation right agreement sales guidance to 1,300-1,400 units at higher 28.8% average deferred management fees, completes Kevin Hickman and Nellie Melba village stages, appoints Richard Stephenson as Chief Development and Property Officer for 2026 and sells land assets including Park Terrace for NZ$42 million and Mount Eliza for NZ$35 million as part of a land bank review.